Amoxicillin and Clavulanate Potassium for Oral Suspension (7:1)

Amoxicillin and Clavulanate Potassium for Oral Suspension (7:1)
Product Description

Infections caused by susceptible strains of the designated organisms in the conditions listed below:1) Lower respiratory Tract infections
2) Otitis Media
3) Sinusitis
4) Urinary Tract Infections

Read more Show less

Bright Future Pharmaceutical Group

  • HK
  • 2018
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Hong Kong, S.A.R., China
More specifications Fewer specifications
Sales Markets
Show more Show less

Bright Future Pharmaceutical Group

  • HK
  • 2018
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
View company profile

More Products from Bright Future Pharmaceutical Group (2)

  • Amoxicillin Capsules 250mg

    Product Amoxicillin Capsules 250mg

    Infections caused by sensitive bacteria, such as:1) Respiratory tract infection (pneumonia, acute and chronic bronchitis, tonsillitis, otitis media, etc.);
    2) Reproductive urinary tract infection (gonorrhea, urethritis, cystitis, pyelonephritis, etc.);
    3) Skin and soft tissue infection;
    4) t...
  • Amoxicillin capsules 500mg

    Product Amoxicillin capsules 500mg

    Infections caused by sensitive bacteria, such as:1) Respiratory tract infection (pneumonia, acute and chronic bronchitis, tonsillitis, otitis media, etc.);
    2) Reproductive urinary tract infection (gonorrhea, urethritis, cystitis, pyelonephritis, etc.);
    3) Skin and soft tissue infection;
    4) typhoid...

Bright Future Pharmaceutical Group resources (1)